The well-known
tumor suppressor p53 inhibits the formation of various
cancers by inducing cell cycle arrest and apoptosis. Although p53 mutations are commonly found in many
cancers, p53 is functionally inactivated in
tumor cells that retain wild-type p53. Here, we show that the
ligand of numb
protein X1 (LNX1) inhibited p53-dependent transcription by decreasing the half-life of p53. We generated LNX1 knockout (KO) cells in p53 wild-type
cancer cells (A549, HCT116, and MCF7) using the clustered regularly interspaced short palindromic repeats (CRISPR)-
CRISPR-associated protein 9 gene-editing system. LNX1 KO activated p53-dependent transcription by increasing the stability of p53. Moreover, lentivirus-mediated overexpression of LNX1 decreased p53
protein levels and inhibited p53-dependent transcription. LNX1 interacted with p53 and mouse double minute 2 (MDM2) and increased the ubiquitination of p53 in an MDM2-dependent manner. Finally, we demonstrated that LNX1 was required for efficient
tumor growth both in cell culture and in a mouse
tumor xenograft model. These results collectively indicated that LNX1 contributed to
tumor growth by inhibiting p53-dependent signaling in p53 wild-type
cancer cells.-Park, R., Kim, H., Jang, M., Jo, D., Park, Y.-I., Namkoong, S., Lee, J. I., Jang, I.-S., Park, J. LNX1 contributes to
tumor growth by down-regulating p53 stability.